Answers are grounded in this paper and cite their sources.
This study evaluated dietary glucose oxidase (GOD) supplementation in broilers challenged with NE. A total of 720 one-day-old Cobb 500 chicks were assigned to six treatments: unchallenged control (UC); challenged control (CC); CC+ antibiotic (salinomycin + bacitracin; 500 g/t each) (ANT), and CC supplemented with GOD at 100, 200, and 300 g/t (GOD100, GOD200, GOD300). All groups except UC were challenged with Eimeria spp. and Clostridium perfringens. Before challenge (day 0–8), GOD supplementation improved weight gain (AWG) and feed conversion ratio (FCR) except GOD300 (both p < 0.001). During day 9–19, CC birds exhibited impaired AWG and FCR (p < 0.001) and increased intestinal lesions and serum fluorescein isothiocyanate dextran (FITC-d) concentrations. Under challenge, GOD100 increased gross energy (p < 0.001) and crude protein (p < 0.01) digestibility relative to CC groups, while GOD200 improved litter scores (p < 0.05). GOD300 showed lower foot pad dermatitis scores than UC and ANT, but did not differ from CC. All GOD doses showed intermediate values in lesion scores, oocyst counts, serum FITC-d, and Production Efficiency Factor (except GOD200), which did not differ from those of CC group or UC and ANT groups (p > 0.05). Despite no significant overall growth benefit over CC, GOD showed potential to improve selected digestive and welfare outcomes under NE challenge.
No takes yet. Share an insight, caveat, or question.
Akter et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: